A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...